Intrauterine Growth Restriction Clinical Trials

Find Intrauterine Growth Restriction Clinical Trials Near You

PlaCEUS: Feasibility Study of Contrast-enhanced Ultrasound to Visualize Maternal Uterine Spiral Arteries Postpartum.

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

During pregnancy, unique blood vessels form within the uterine wall, known as spiral arteries. These vessels originate from the uterine artery, which is the main artery supplying blood to the uterus. Throughout pregnancy, spiral arteries undergo significant changes to increase blood and oxygen flow to the placenta, ensuring the developing baby receives adequate nutrients. When these arteries fail to remodel properly, complications such as pre-eclampsia or fetal growth restriction can occur. Until now, direct observation and evaluation of spiral arteries during pregnancy has not been feasible. Contrast-enhanced ultrasound may provide a breakthrough in this area. In this study, the investigators aim to use this imaging technique to visualize spiral arteries after the placenta has been delivered. If successful, this could allow to assess their structural quality. Additionally, the investigators will employ ultrasound to monitor physiological changes in the uterine artery during late pregnancy (after 37 weeks), during labour, and postpartum. By conducting these measurements, the investigators hope to develop methods for detecting spiral artery abnormalities earlier in pregnancy. Early identification could enable timely interventions and help prevent severe complications.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Pregnant patient at a minimum age of 18 years

• Singleton pregnancy at term (≥37 weeks gestation)

• Planning to deliver at the Máxima Medical Centre

• Able to provide informed consent

• Intravenous access present at the time of delivery

Locations
Other Locations
Netherlands
Máxima Medical center
RECRUITING
Veldhoven
Contact Information
Primary
Eveline Dekker, Drs
e.dekker@mmc.nl
+3140 888 83 80
Backup
Loes Monen, Dr.
+3140 888 83 80
Time Frame
Start Date: 2025-12-17
Estimated Completion Date: 2026-07-01
Participants
Target number of participants: 5
Treatments
Experimental: CEUS
All participants included in the study will receive contrast enhanced ultrasound imaging postpartum. During pregnancy, during labour and postpartum Doppler parameters of the uterine arterie will be performed.
Sponsors
Leads: Maxima Medical Center

This content was sourced from clinicaltrials.gov